LIFE SCIENCES 2018-03-22T17:59:01+00:00

Life Sciences Team

Our Life Sciences team are hugely experienced in the application of legal knowledge within a broad range of commercial scenarios and practice areas:

As a firm, we are well equipped to advise in the life science specific areas of IP law, including the ever-evolving area of Supplementary Protections Certificates or ‘SPCs’. Our life science professionals understand client perspective, with a significant number having worked within industry management positions. These attorneys are highly skilled in freedom to operate projects, product portfolio management and launch strategies.

The Avidity Life Sciences team fully appreciates the broader commercial implications of patents and applications; our senior attorneys have undertaken external IP due diligence within the context of investment planning, e.g. stock market listing/IPO, as well as other transactional work, such as company mergers and acquisitions. Concerning more contentious matters, our attorneys have established close working relationships with well-regarded members of chambers and technical experts to support litigation in this technical area.


Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Biologics are isolated from a variety of natural sources – human, animal, or microorganism and produced from developing the cells in culture and other biotechnology methods and cutting-edge technologies.

Biological products often represent the cutting-edge of biomedical research and, in time, may offer the most effective means to treat a variety of medical illnesses and conditions that presently have no other treatments available. Our team has secured valuable patents for clients in this vibrant area of life sciences.


Pharmaceutics is the discipline that deals with the process of turning a New Chemical Entity (NCE), or old drug formulations, into a medication to be used safely and effectively by patients. It is also called the science of dosage form design.

The aim of pharmaceutical development is to design a quality product and its manufacturing process to consistently deliver the intended performance of the drug and its dosage. Formulation of a drug is designed to ensure that the correct dose is delivered, the core substance is protected and the pharmacokinetic behaviour of the drug is altered.

It is through partnership with our Avidity-IP team that we secure valuable commercial life extension and ensure maximum value is extracted for clients pharma discoveries through Supplementary Protection Certificates (SPC). We also work with clients to investigate freedom to operate to exploit specific drug formulations or re-discovery phases in new applications.


Chemistry plays an important role in the life sciences, explaining the shapes and properties of biomolecules, and helping to provide an understanding of how biological processes work at a molecular level.

Our team have expertise and experience in handling inventions in the chemical field and related areas.
Typical areas might include: Food chemistry, Crystal chemistry, Novel chemical entities, Coatings, Composite materials, Encapsulation technology.


The application of herbicide, insecticide and fungicide active substances is fundamental to control serious dangers to plant health.

Key intellectual property activities in this area have included IP portfolio evaluation and review as well as supporting due diligence assessments.

Personal Care

The cosmetics and personal care industry is a fast-paced and highly innovative sector that is driven by science. To remain competitive Avidity-IP supports clients identify areas of differentiation and freedom to operate to exploit a valuable niche in this competitive industry.

Health Care

Health Care supports a broad spectrum of technologies that support the provision and delivery of health care. This could include: Medicinal products; Wound dressings; Diagnostic tests; Inhalable formulations and Biosensors.

Digital health – the broad term encompassing fields at the intersection between healthcare and technology, including mHealth, wearables and more – is also a very active area for startup investments. And digital health funding is growing rapidly. This area has great potential for generating new value from innovation, but competition can be fierce. Success requires a sophisticated strategy to sustain competitive advantages and preserve the value of intellectual property for attracting future stakeholders. Avidity-IP can support this strategic development.